PRF Technologies (PRFX) Prepaid Assets (2019 - 2025)
PRF Technologies (PRFX) posted quarterly Prepaid Assets of $185000.0 for Q4 2025, up 17.83% year-on-year from $157000.0 in Q4 2024, and down 55.42% on a QoQ basis from $415000.0 in Q2 2025.
PRF Technologies (PRFX) Prepaid Assets (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Prepaid Assets for 7 consecutive years, with $185000.0 the latest figure, recorded in Q4 2025.
- Quarterly Prepaid Assets rose 17.83% year-over-year to $185000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $185000.0 (up 17.83% YoY) and the FY2025 annual result came in at $185000.0, up 17.83% from the prior year.
- Prepaid Assets retreated to $185000.0 in Q4 2025 per PRFX's latest filing, from $415000.0 in the prior quarter.
- Over the last five years, Prepaid Assets for PRFX reached as high as $1.7 million in Q4 2021 and fell as low as $13000.0 in Q4 2023.
- A 5-year average of $427764.7 and a median of $214000.0 in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets soared 1914.29% — and 2023, when it plunged 99.25%.
- Year by year, Prepaid Assets stood at $1.7 million in 2021, then changed by 0.0% to $1.7 million in 2022, then tumbled by 99.25% to $13000.0 in 2023, then soared by 1107.69% to $157000.0 in 2024, then rose by 17.83% to $185000.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $185000.0, $415000.0, and $157000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 185,000.00 |
| Jun 30, 2025 | 415,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Jun 30, 2024 | 199,000.00 |
| Mar 31, 2024 | 201,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 154,000.00 |
| Mar 31, 2023 | 264,000.00 |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 337,000.00 |
| Mar 31, 2022 | 482,000.00 |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 212,000.00 |
| Jun 30, 2021 | 282,000.00 |
| Mar 31, 2021 | 601,000.00 |
| Dec 31, 2020 | 1.29 Mn |
| Jun 30, 2020 | 14,000.00 |
| Dec 31, 2019 | 25,000.00 |